Filing Details
- Accession Number:
- 0000899243-22-039302
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-23 16:05:15
- Reporting Period:
- 2022-12-21
- Accepted Time:
- 2022-12-23 16:05:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
31791 | Perkinelmer Inc | PKI | Laboratory Analytical Instruments (3826) | 042052042 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1408107 | S Tajinder Vohra | 940 Winter Street Waltham MA 02451 | Please See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-12-21 | 1,662 | $48.98 | 18,867 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-12-21 | 362 | $140.57 | 18,505 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-12-21 | 712 | $142.50 | 17,793 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-12-21 | 588 | $143.47 | 17,205 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2022-12-22 | 1,663 | $48.98 | 18,868 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-12-22 | 580 | $139.21 | 18,288 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-12-22 | 673 | $140.37 | 17,615 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-12-22 | 410 | $141.12 | 17,205 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | NQ Stock Option (right to buy) | Disposition | 2022-12-21 | 1,662 | $0.00 | 1,662 | $48.98 |
Common Stock | NQ Stock Option (right to buy) | Disposition | 2022-12-22 | 1,663 | $0.00 | 1,663 | $48.98 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
1,663 | 2023-03-04 | No | 4 | M | Direct | |
0 | 2023-03-04 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Vohra on November 16, 2022.
- The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $140.25 to $140.74. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $142.13 to $143.09. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $143.25 to $143.66. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $138.85 to $139.72. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $139.95 to $140.75. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $140.95 to $141.36. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- This option became exercisable in three equal annual installments beginning on March 4, 2017, which was the first anniversary of the date on which the option was granted.